PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32585603-0	2020	The effect of olmesartan on aortic intimal thickening after balloon injury through Apelin/APJ.	olmesartan	14-24	apelin receptor	Rattus norvegicus	90-93	
32585603-12	2020	Olmesartan decreased the expression of Ang II and AT1, but further increased the expression of Apelin and APJ.	olmesartan	0-10	apelin receptor	Rattus norvegicus	106-109	
32585603-14	2020	CONCLUSION: Olmesartan inhibits the intimal thickening through activating Apelin/APJ and inhibiting AngII-AT1 and ERK pathway.	olmesartan	12-22	apelin receptor	Rattus norvegicus	81-84	
19904215-2	2010	We investigated whether angiotensin II receptor blocker olmesartan could improve cardiac function associated with apelin/APJ and Akt/endothelial nitric oxide synthase (eNOS) pathway in Dahl salt-sensitive hypertensive (DS) rats with end-stage heart failure using NOS inhibitor L-N(G)-nitroarginine methyl ester (L-NAME).	olmesartan	56-66	apelin receptor	Rattus norvegicus	121-124	
24770651-5	2014	Administration of the AT1R antagonist olmesartan resulted in the restoration of the reduction of apelin and APJ expressions induced by AngII for 48 h in 3T3-L1 adipocytes.	olmesartan	38-48	apelin receptor	Rattus norvegicus	108-111	
19904215-6	2010	Downregulation of apelin and APJ expression and phosphorylation of Akt and eNOS in failing rats were significantly increased by olmesartan.	olmesartan	128-138	apelin receptor	Rattus norvegicus	29-32	
19904215-8	2010	These findings suggest that olmesartan may improve cardiac dysfunction and remodeling associated with apelin/APJ and Akt/eNOS pathway in DS rats with end-stage heart failure.	olmesartan	28-38	apelin receptor	Rattus norvegicus	109-112